C. R. Bard, Inc.

A targeted temperature management (TTM) system includes a TTM module configured to provide a TTM fluid and a pad configured to facilitate thermal energy transfer between the TTM fluid and a patient. The system includes a fluid delivery line (FDL) with a hub at the distal end of the FDL. The pad includes a connector including a flapper valve configured to alternate between open and closed positions based on whether the connector is coupled with the FDL hub. The flapper valve in the closed position covers openings of each of the fluid delivery conduit and fluid return conduit when the connector is uncoupled from the FDL hub. The flapper valve is configured to deform into the open position upon coupling of the connector and the FDL hub thereby establishing fluid communication therebetween.

Disclosed herein are female external catheters (“FECs”) and methods thereof. For example, an FEC can include a catheter body, a catheter back, and a connector. The catheter body can include a cavity extending along a length of the catheter body. The cavity is configured to open toward a patient. The catheter back can include a connector hole aligned with an end portion of the cavity. The connector hole can be configured to open away from the patient. The connector is disposed in the connector hole. The connector can include a sump configured to collect urine from the end portion of the cavity for withdrawal from the FEC. In another example, a method of an FEC can includes a method of using the FEC.

A system for providing a medical treatment, including a first medical instrument and a second medical instrument is disclosed. The first medical instrument includes a first operator interface configured to define a plurality of operating parameters of the first medical instrument. The second medical instrument includes a second operator interface configured to define a subset of the plurality of operating parameters. The first operator interface is configured for placement and use outside of a sterile field and the second operator interface is configured for placement and use within the sterile field. The second operator interface is attached to or attachable to a handle of the second medical instrument. The handle is configured for manipulation by a hand of the operator and the second operator interface is configured for interaction with one or more extremities of the same hand.

Disclosed herein is a system, apparatus and method directed to automated adjustment of a positioning of a drainage bag based on at least an amount of tension within a tubing extending from the drainage bag. The system, apparatus and method pertain to an automated drainage bag actuation system that includes at least a first railing, a control box coupled to the first railing and configured to receive mounting fasteners that couple a drainage bag to the control box, the control box including a tension load cell sensor, a first motor, and circuitry electrically coupled to the first motor and the tension load cell sensor. The circuitry is configured to receive data from the tension load cell sensor indicating an amount of tension in tubing extending from the drainage bag and transmit one or more electrical signals to activate the first motor causing adjustment of a positioning of the drainage bag.

Drug-loaded microbead compositions include microbeads of a water-swellable polymer material and a complex of a carrier and a therapeutic agent chemically bonded to the carrier. The complex is embedded in the polymer material. Methods for preparing the drug-loaded microbead compositions and embolization compositions include loading a therapeutic agent into a water-swellable polymer material to form microbeads, then removing water from the microbeads. Additional drug-loaded microbead compositions include microbeads of a biodegradable material, vesicular agents, a first therapeutic agent associated with the vesicular agents, and a second therapeutic agent different from the first therapeutic agent. The vesicular agents include a lipid bilayer surrounding a vesicular core. The second therapeutic agent is contained within the microbeads or associated with the microbeads through ionic or non-covalent interaction and may or may not be associated with the vesicular agents. Drug-loaded biodegradable microbead compositions include microbeads of biodegradable material and a therapeutic agent.

A low-profile access port for subcutaneous implantation within a patient is disclosed. The access port includes a receiving cup that provides a relatively large subcutaneous target to enable catheter-bearing needle access to the port without difficulty. In one embodiment, a low-profile access port comprises a body including a conduit with an inlet port at a proximal end, and a receiving cup. The receiving cup is funnel shaped to direct a catheter-bearing needle into the conduit via the inlet port. The conduit is defined by the body and extends from the inlet port to an outlet defined by a stem. A bend in the conduit enables catheter advancement past the bend while preventing needle advancement. A valve/seal assembly is also disposed in the conduit and enables passage of the catheter therethrough while preventing fluid backflow. The body includes radiopaque indicia configured to enable identification of the access port via x-ray imaging.

A device for introduction into a body vessel includes a shaft ( 105 ), a balloon ( 115 ) positioned at the distal end of the shaft ( 105 ), and at least one longitudinal scoring wire ( 135 ) to score a vascular lesion attached to the distal end of the shaft ( 105 ), disposed over the balloon ( 115 ). The shaft ( 105 ) includes a support ( 119 ), such as a wire or tube having one or more spirally cut portions ( 119 A, 119 B), which improves pushability and trackability, thereby allowing for use with an external guidewire in a “short rapid exchange” (SRX) format. The balloon ( 115 ) expands when fluid is delivered to the balloon ( 115 ) through the inflation lumen. This expansion pushes the scoring wire and guidewire against the vascular lesion.

Systems and methods directed to a renal sheath, one or more electrode pairs in the renal sheath, and a wiring system configured to connect the one or more electrode pairs to an electric current. The renal sheath can include a distal end portion, a proximal end portion, and a medial portion between the distal and proximal end portions. The medial portion can include the one or more electrode pairs. The one or more electrode pairs can be configured to produce heat sufficient to induce hemostasis in bleeding tissue surrounding the renal sheath. The wiring system can be configured to connect the one or more electrode pairs to the electric current to produce the heat sufficient to effect the hemostasis. In some embodiments, an electrosurgical generator can be configured to provide an alternating current to the one or more electrode pairs to produce the heat sufficient to effect the hemostasis.

An intermittent-catheter assembly ( 100 ) includes an intermittent catheter and a catheter housing ( 102 ). The intermittent catheter includes a funnel and a catheter tube fluidly coupled to the funnel. The catheter housing ( 102 ) includes the intermittent catheter disposed in the catheter housing while in a packaged state of the intermittent-catheter assembly. The catheter housing includes an inner sleeve ( 104 ) and an outer sleeve ( 102 ). The inner sleeve ( 104 ) includes a longitudinal cavity containing a majority of the intermittent catheter in the packaged state of the intermittent-catheter assembly. The outer sleeve ( 106 ) is slidably disposed over the inner sleeve ( 104 ). The catheter housing ( 102 ) is configured to expose the intermittent catheter for removal from the catheter housing ( 102 ) when the outer sleeve ( 106 ) is grasped and slid toward an exposed end of the inner sleeve ( 104 ) in opposition to a force applied to the exposed end of the inner sleeve ( 104 ).

Disclosed herein is a medical device projection system. The medical device projection system includes a first medical device outside of a sterile field, the first medical device having a user control interface including a plurality of parameters. The medical device projection system further includes a projector within the sterile field, the projector in communication with the first medical device and configured to project a mixed reality visual representation of the user control interface on a surface.